Moratalla-Navarro, F.; DÃez-Villanueva, A.; Garcia-Serrano, A.; Closa, A.; Cordero, D.; Solé, X.; Guinó, E.; Sanz-Pamplona, R.; Sanjuan, X.; Santos, C.;
et al. Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer. Cancers 2023, 15, 3301.
https://doi.org/10.3390/cancers15133301
AMA Style
Moratalla-Navarro F, DÃez-Villanueva A, Garcia-Serrano A, Closa A, Cordero D, Solé X, Guinó E, Sanz-Pamplona R, Sanjuan X, Santos C,
et al. Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer. Cancers. 2023; 15(13):3301.
https://doi.org/10.3390/cancers15133301
Chicago/Turabian Style
Moratalla-Navarro, Ferran, Anna DÃez-Villanueva, Ainhoa Garcia-Serrano, Adrià Closa, David Cordero, Xavier Solé, Elisabet Guinó, Rebeca Sanz-Pamplona, Xavier Sanjuan, Cristina Santos,
and et al. 2023. "Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer" Cancers 15, no. 13: 3301.
https://doi.org/10.3390/cancers15133301
APA Style
Moratalla-Navarro, F., DÃez-Villanueva, A., Garcia-Serrano, A., Closa, A., Cordero, D., Solé, X., Guinó, E., Sanz-Pamplona, R., Sanjuan, X., Santos, C., Biondo, S., Salazar, R., & Moreno, V.
(2023). Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer. Cancers, 15(13), 3301.
https://doi.org/10.3390/cancers15133301